6533b7d9fe1ef96bd126c051
RESEARCH PRODUCT
Meta-analysis of blood pressure (BP) reductions with olmesartan medoxomil (OM) compared with active control (AC) in patients (pts) with hypertension (HTN)
Ji-guang WangJoris VerstedenKazuomi KarioPaul-egbert ReimitzPrakash DeedwaniaJosep Redonsubject
medicine.medical_specialtybusiness.industryActive controlEndocrinologyBlood pressureInternal medicineMeta-analysisInternal MedicinemedicineIn patientCardiology and Cardiovascular MedicinebusinessOlmesartanmedicine.drugdescription
Meta-analysis of blood pressure (BP) reductions with olmesartan medoxomil (OM) compared with active control (AC) in patients (pts) with hypertension (HTN) Josep Redon,y, 6 Prakash Deedwania, Kazuomi Kario, Jiguang Wang, Joris Versteden, Paul-Egbert Reimitz. Daiichi Sankyo Europe GmbH, Munich, Germany; Daiichi Sankyo Europe GmbH, Munich, Germany; Jichi University School of Medicine, Japan; Shanghai Institute of Hypertension, Shanghai, China; University of California San Francisco, San Francisco, CA, United States; University of Valencia, Madrid, Spain
year | journal | country | edition | language |
---|---|---|---|---|
2015-04-01 | Journal of the American Society of Hypertension |